CLL patients exhibited variable TACI expression, with the majority of cases displaying low to undetectable TACI, along with low to undetectable BAFF and increased APRIL serum levels compared to healthy controls. Here, TNFSF13 is linked to B-cell chronic lymphocytic leukemia.